The results are consistent with in vitro findings related to adipose-derived stem cells (ASCs) and their production of adipsin and leptin as part of fat-related abnormal proteins that could explain their different abilities to promote the growth of breast cancer tumor cells from surgical specimens. The gene discussed is LEP; the disease is breast carcinoma.